Printer Friendly

DUN & BRADSTREET SUBSIDIARY TO MONITOR HIV/AIDS NATIONALLY FOR CENTERS FOR DISEASE CONTROL

 SCHAUMBURG, Ill., Nov. 18 /PRNewswire/ -- Dun & Bradstreet HealthCare Information, a division of The Dun & Bradstreet Corporation (NYSE: DNB), announced today that it has been awarded a cooperative agreement by the Centers for Disease Control (CDC) to conduct a study designed to monitor HIV/AIDS trends and treatment patterns in five geographic areas across the country.
 Under the agreement, the Health Research Network, operated by Dun & Bradstreet HealthCare Information, will conduct a two-part study of HIV-infected individuals under the care of infectious disease physicians in Atlanta, Los Angeles, San Francisco, Tampa, Fla. and Portland, Ore. Thomas E. Gardner, president and CEO of Dun & Bradstreet HealthCare Information, Inc., said: "Physicians participating in the Health Research Network represent a significant and rapidly expanding group whose practices parallel the HIV/AIDS epidemic. This in-depth, longitudinal study will provide physicians a national database of HIV- infected patients that will give them a new weapon in their fight against this disease."
 The study will create a national database that will track the incidence of AIDS-related conditions and monitor trends in prevention, treatment and other aspects of the disease complex.
 The study also will collect data at the designated sites on the cost of caring for such AIDS-related illnesses as pneumocystis carinii pneumonia (PCP) -- one of the most common AIDS-related infections to identify the most cost-effective management of these conditions.
 This part of the study is consistent with the current national need in health care to utilize outcome measures and to demonstrate high-quality, cost-effective care. The methods developed, which assure complete patient confidentiality, will serve as a model for the study of other HIV-related illnesses.
 "The data collected at each patient visit includes demographic, clinical and other health-related information which will allow for rapid analysis of the changing trends, disease patterns and outcomes of care," said Dr. Steven I. Marlowe of Atlanta, the study's principal investigator.
 The CDC will receive data within 60-to-90 days after each patient visit, allowing for almost immediate insight into changes in the AIDS epidemic. Delivery of data in a PC-database format enables the CDC to quickly produce numerous ad hoe analyses.
 Dr. Scott Holmberg, a co-project officer with the CDC, added: "Close cooperative relationships with leading infectious diseases physicians will allow the CDC to monitor changes in leading-edge treatments often seen in such sites."
 This study will help answer such questions as:
 -- Which drug or combination of medications is most efficient in managing severe AIDS-related illnesses such as CMV retinitis, which can lead to blindness, or mycobacterium avium complex.
 -- During the course of their disease, at what times are persons with HIV most vulnerable to various infections and malignancies?
 -- Are certain treatments stopped because they are too toxic and generate undesirable side-effects? Do insurers or governmental programs restrict these treatments?
 -- To what extent are health care resources consumed by AIDS patients with PCP? Are there ways to reduce the costs of health care while maintaining high-quality results (i.e., treating patients with potent and high-tech therapies at home rather than in the hospital)?
 The five sites currently participating in the study will be linked via Dun & Bradstreet HealthCare Information software systems used for data collection, and data will be made available to the CDC quarterly.
 The approximately 50 Health Research Network physicians represent a large clinical network with responsibility for the care of 5,000 to 10,000 HIV-infected patients nationwide.
 The Dun & Bradstreet Corporation is the world's leading marketer of information software and services for business decision-making, with worldwide revenue of $4.8 billion in 1992.
 -0- 11/18/93
 /CONTACT: Diane J. Fisher of D&B HealthCare Information, 708-995-7442; Bob Marquis or Marc Weinstein of Princeton PR Group, Inc., 908-873-5588/
 (DNB)


CO: Dun & Bradstreet HealthCare Information; Health Research Network;
 Centers for Disease Control ST: Illinois, Georgia IN: HEA SU:


WB-TW -- NY052 -- 6042 11/18/93 12:42 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 18, 1993
Words:638
Previous Article:COMPUTER CITY OPENS FIRST SUPERCENTER IN HAWAII
Next Article:NUVEEN FUNDS DISCLOSE ADDITIONAL TERMS OF REOPENINGS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters